March 29, 2023
Ophthorobotics today announced that its Board of Directors has appointed Miguel Serrano as Chief Executive Officer and member of the board of directors, effective June 1st, 2021.
He will succeed Prof. Franziska Mathis-Ullrich who served as the CEO since 2016. Serrano previously served as Corporate Vice President at Medtronic.
Miguel has held numerous global leadership roles in healthcare over the last 15 years with a strong record of accomplishments in driving commercial excellence and a proven leader with innovative business vision and the ability to bring people together through a culture of inclusiveness and integrity.
“His vision for healthcare and experience around the world will help Ophthorobotics enter its next chapter of product innovation and growth, leading the expected upcoming launches of our transformative ophthalmic robotic solutions”, said the company.
Regarding his appointment, Miguel Serrano said: "I'm honored to have been chosen to lead the company. The opportunity ahead of us is vast and I am excited to lead and develop Ophthorobotics into the leading partner for robotically- assisted ophthalmic treatments around the world.”
Ophthorobotics is a swiss technology company, working in close cooperation with leading ophthalmologists and robotic experts at the ETH Zürich on creating transformative treatments for the main ophthalmic diseases, leveraging robotically-assisted technology.
For further information about the company, visit www.ophthorobitcs.com or contact: